In vivo, similar findings were observed in a diabetic cardiomyopathy murine model (gender not specified), as resveratrol (25 mg/kg/d for five days) significantly increased Sirt1, reduced cardiac hypertrophy, and improved ejection fraction, but this was abrogated by Sirt1-specific cardiac deletion. Here, SIRT1 is linked to cardiac hypertrophy.